ESC & iPSC News 5.24, June 23, 2010. |
| | |
TOP STORY Therapeutic Potential of Embryonic Stem Cells Researchers demonstrated slightly lower levels of Nodal and Cripto-1 (Nodal’s co-receptor) and a dramatic decrease in Lefty (Nodal’s inhibitory regulator) in human induced pluripotent stem cells compared with human embryonic stem cells, suggesting less regulatory control of cell fate in reprogrammed stem cells. [Press release from EurekAlert! discussing online prepublication in the Journal of Cellular Physiology]
|
SCIENCE NEWS Dental Pulp Cells for Stem Cell Banking Data demonstrates the promising potential of dental pulp cell collections as a source of cell banks for use in regenerative medicine. [Press release from EurekAlert! discussing online prepublication in the Journal of Dental Research] Stem Cells Made Without New Genes Researchers have transformed human skin cells into stem cells similar to those in an embryo without using any reprogramming genes, just the viral vector normally used to deliver them. [Press release from NatureNews discussing research presented at the 8th Annual Meeting of the International Society for Stem Cell Research]
|
POLICY NEWS President of EFPIA Calls for a ‘New Dialogue’ on Medicines Andrew Witty, CEO of GlaxoSmithKline and President of European Federation of Pharmaceutical Industries and Associations (EFPIA), the body representing the research-based pharmaceutical industry in Europe, called for ‘a new dialogue’ between governments and the pharmaceutical industry in order to deliver patient access to better medicines and enhance Europe’s competitiveness as a base for R&D investment. [European Federation of Pharmaceutical Industries and Associations, European Union] New Videos Reveal How NIH Identifies the Most Promising Research Applications The National Institutes of Health’s (NIH) Center for Scientific Review released a new video to show new applicants and others how NIH assesses over 80,000 grant applications each year to help find those with the most merit. [National Institutes of Health, United States] NIH and Wellcome Trust Announce Partnership to Support Genomic, Population-Based Studies in Africa The National Institutes of Health (NIH) and the Wellcome Trust announced a partnership with African researchers to conduct genetic and environmental studies in Africa of common, non-communicable disorders, such as heart disease and cancer, as well as communicable diseases, such as malaria. [National Institutes of Health, United States] FDA Pushes Orphan Drug Research The Food and Drug Administration (FDA) published a list of 235 treatments that may have benefit in rare disorders and already have marketing clearance for other uses. [Food and Drug Administration, United States] Publication of New Enforcement Strategy A new enforcement strategy has been published by the Inspection, Enforcement and Standards Division. [Medicines and Healthcare Products Regulatory Agency, United Kingdom] Risk Evaluation and Mitigation Strategy Public Meeting [Center for Biologics Evaluation and Research, United States] Currently Approved CBER NDAs/ANDAs [Center for Biologics Evaluation and Research, United States] Drugs Designated as Orphan Drugs [Therapeutic Goods Administration, Australia]
|
EVENTS Worldwide Innovative Networking (WIN) Symposium in Personalized Cancer Medicine July 7-9, 2010 Paris, France United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference July 12-14, 2010 Nottingham, United Kingdom
2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2) August 2-4, 2010 Singapore
Select Biosciences 3rd Annual Stem Cells Europe Conference August 24-25, 2010 Edinburgh, Scotland Select Biosciences Inaugural Cellular Therapy Summit August 24-25, 2010 Edinburgh, Scotland
International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting September 11-14, 2010 Belgirate, Italy
Stem Cells USA & Regenerative Medicine Congress 2010 September 13-15, 2010 Philadelphia, United States Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010 September 15-17, 2010 Sydney, Australia 5th World Congress on Preventive & Regenerative Medicine (WCRM) 2010 October 5-7, 2010 Hannover, Germany
Fraunhofer Life Science Symposium Leipzig 2010 October 29-30, 2010 Leipzig, Germany
Select Biosciences 2nd International Forum on Stem Cells November 12-13, 2010 Tianjin, China Stem Cell Network 10th Annual Scientific Meeting November 22-24, 2010 Calgary, Canada Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference December 5-8, 2010 Orlando, United States
Stem Cells World Congress January 24-25, 2011 San Diego, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with ESC & iPSC News. Visit here to post your career opportunities.
|
|
|
|